Company intelligence / Profile preview
Nicopharm
- Ownership
- Private
- Development stage
- Other
Overview
Nicopharm (officially registered as Nicopharm Pty Limited) was an Australian pharmaceutical company and compounding pharmacy that specialized in providing locally compounded liquid nicotine solutions for smoking cessation. Established around 2015, the company operated under a regulatory compounding exemption to supply prescription-only liquid nicotine to patients in Australia, serving as a key alternative to importing nicotine from overseas. Nicopharm's products were widely utilized in clinical trials and academic research evaluating the efficacy of electronic cigarettes and combination nicotine replacement therapies. The company ceased operations under the Nicopharm name around 2021, with its services subsequently transitioning to Quit Doctors.
- Therapeutic areas
- Psychiatry
- Modalities
- Small molecule
- Industry
- Pharma
Drug pipeline
1 assetBeyond the preview
Go deeper on Nicopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nicopharm.